Showing results (1381-1390 of 1,436) with videos related to

Sort By:
Pageof 144
The Journal of Allergy and Clinical Immunology|April 29, 2014
Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spotsGiancarlo la Marca, Clementina Canessa, Elisa Giocaliere, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 StudyMichael Wang, Javier Munoz, Andre Goy, et al.
Lancet (London, England)|May 21, 2013
Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysisAudrey Prost, Tim Colbourn, Nadine Seward, et al.
Gastroenterology|August 18, 2020
S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and InfantsMaike Willers, Thomas Ulas, Lena Völlger, et al.
Lancet (London, England)|June 4, 2017
Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trialMichael S Avidan, Hannah R Maybrier, Arbi Ben Abdallah, et al.
Tomography (Ann Arbor, Mich.)|April 27, 2023
An Online Repository for Pre-Clinical Imaging Protocols (PIPs)Seth T Gammon, Allison S Cohen, Adrienne L Lehnert, et al.
British Journal of Haematology|November 5, 2019
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemiaToby A Eyre, Lindsey E Roeker, Christopher P Fox, et al.
The New England Journal of Medicine|April 4, 2020
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaMichael Wang, Javier Munoz, Andre Goy, et al.
Photoacoustics|August 21, 2023
A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoptionHisham Assi, Rui Cao, Madhura Castelino, et al.
Lancet (London, England)|April 20, 2020
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trialJeff P Sharman, Miklos Egyed, Wojciech Jurczak, et al.
Pageof 144